Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
225.3 USD | -0.02% |
|
+1.35% | +9.76% |
07-09 | Baird Adjusts Cencora's Price Target to $285 From $280, Keeps Outperform Rating | MT |
07-09 | TD Cowen Adjusts Cencora's Price Target to $271 From $265, Keeps Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.76% | 44.38B | |
-4.59% | 179B | |
-2.76% | 100B | |
-7.46% | 46.16B | |
+18.16% | 44.81B | |
+13.63% | 29.53B | |
+22.31% | 25.83B | |
-7.35% | 23.97B | |
+4.19% | 22.5B | |
-8.46% | 22.11B |
- Stock Market
- Equities
- COR Stock
- News Cencora, Inc.
- Transcript : AmerisourceBergen Corporation Presents at Goldman Sachs 12th Annual Healthcare CEOs Unscripted